# Hangrong Chen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hangrong-chen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,217 |
| Field | Nanoplatforms for cancer theranostics |
| h-index | 84 |
| i10-index | 256 |
| Last Known Institution | Chinese Academy of Sciences |
| OpenAlex ID | https://openalex.org/A5013084576 |
| ORCID iD | https://orcid.org/0000-0003-0827-1270 |
| Works | 347 |

## Researcher papers

- [Hollow/Rattle-Type Mesoporous Nanostructures by a Structural Difference-Based Selective Etching Strategy](https://scholariq.org/papers/hollow-rattle-type-mesoporous-nanostructures-by-a-structural-difference-based/)
- [Core/Shell Structured Hollow Mesoporous Nanocapsules: A Potential Platform for Simultaneous Cell Imaging and Anticancer Drug Delivery](https://scholariq.org/papers/core-shell-structured-hollow-mesoporous-nanocapsules-a-potential-platform-for/)
- [Biocompatible PEGylated MoS2 nanosheets: Controllable bottom-up synthesis and highly efficient photothermal regression of tumor](https://scholariq.org/papers/biocompatible-pegylated-mos2-nanosheets-controllable-bottom-up-synthesis-and/)

## Researcher topics

- [Nanoplatforms for cancer theranostics](https://scholariq.org/topics/nanoplatforms-for-cancer-theranostics/)
- [Catalytic Processes in Materials Science](https://scholariq.org/topics/catalytic-processes-in-materials-science/)
- [Nanoparticle-Based Drug Delivery](https://scholariq.org/topics/nanoparticle-based-drug-delivery/)
- [Mesoporous Materials and Catalysis](https://scholariq.org/topics/mesoporous-materials-and-catalysis/)
- [Electrocatalysts for Energy Conversion](https://scholariq.org/topics/electrocatalysts-for-energy-conversion/)

## Researcher university

- [Chinese Academy of Sciences](https://scholariq.org/institutions/chinese-academy-of-sciences/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.